论文部分内容阅读
近年干扰素 (ｉｎｔｅｒｆｅｒｏｎ ,ＩＦＮ)治疗肿瘤的作用渐受重视。它可通过活化免疫细胞发挥效力 ,但因活化细胞瘤区者数量少 ,疗效不佳[1] 。瘤内给药有肯定疗效[2 ] ,却还难被广泛认同。我们从 1993年起以瘤内、外注射ＩＦＮ对照治疗难以手术或化疗不敏感的实体瘤 ,并进?
In recent years, the role of interferon (IFN) in the treatment of tumors has received increasing attention. It can be activated by activating immune cells, but because of the small number of activated area of the tumor, the curative effect is poor [1]. Intratumoral administration has a positive effect [2], but still difficult to be widely recognized. We started with intratumoral injection of IFN control from 1993 to treat difficult to surgery or chemotherapy-insensitive solid tumors, and into?